{"name": "Boston Biomedical",
 "permalink": "boston-biomedical",
 "crunchbase_url": "http://www.crunchbase.com/company/boston-biomedical",
 "homepage_url": "http://www.bostonbiomedical.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": 1,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "781-278-0900",
 "description": "Biotechnology Company",
 "created_at": "Tue Apr 12 03:38:20 UTC 2011",
 "updated_at": "Fri Mar 02 03:50:51 UTC 2012",
 "overview": "\u003Cp\u003EBoston Biomedical, Inc. is a privately held biotechnology company focusing on research and development of novel therapeutics to treat cancer.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0013/0137/130137v1-max-150x150.jpg"],
     [[231,
       70],
      "assets/images/resized/0013/0137/130137v1-max-250x250.jpg"],
     [[231,
       70],
      "assets/images/resized/0013/0137/130137v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.genengnews.com/gen-news-highlights/dainippon-sumitomo-pharma-to-snag-boston-biomedical-for-200m/81246427/",
   "source_description": "Dainippon Sumitomo Pharma to Snag Boston Biomedical for $200M",
   "acquired_year": 2012,
   "acquired_month": 2,
   "acquired_day": 29,
   "acquiring_company":
    {"name": "Dainippon Sumitomo",
     "permalink": "dainippon-sumitomo",
     "image":
      {"available_sizes":
        [[[150,
           62],
          "assets/images/resized/0005/8962/58962v1-max-150x150.png"],
         [[250,
           104],
          "assets/images/resized/0005/8962/58962v1-max-250x250.png"],
         [[251,
           105],
          "assets/images/resized/0005/8962/58962v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "333 Providence Highway",
    "address2": "",
    "zip_code": "02062",
    "city": "Norwood",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "signed a license agreement with Dainippon Sumitomo Pharma Co. Ltd. of Osaka, Japan, for BBI's BBI608 candidate compound for all oncology indications",
    "stoned_year": 2011,
    "stoned_month": 4,
    "stoned_day": 11,
    "source_url": "http://www.masshightech.com/stories/2011/04/11/daily9-Boston-Biomedical-in-15-million-plus-deal-with-Dainippon.html",
    "source_text": null,
    "source_description": "Boston Biomedical in $15 million-plus deal with Dainippon",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Boston Biomedical",
      "permalink": "boston-biomedical"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        148],
       "assets/images/resized/0013/0138/130138v1-max-150x150.jpg"],
      [[250,
        247],
       "assets/images/resized/0013/0138/130138v1-max-250x250.jpg"],
      [[450,
        445],
       "assets/images/resized/0013/0138/130138v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}